Advertisement

Early Adenocarcinoma of Barrett’s Esophagus in the East and the West: Is This an Endoscopic or a Surgical Problem?

  • Takuji Gotoda
  • Antonello Trecca
Chapter

Abstract

The authors discuss in this chapter the role of endoscopy in the diagnosis and treatment of esophagogastric junction tumors. Different trends concerning incidence and pathophysiology in the East and in the West are considered together with the current classification of the disease. Modern concepts and societies guidelines for the treatment of these tumors are discussed and compared between eastern and western approach. International collaborative studies would be helpful to improve the detection rate and the clinical outcomes in EGJ tumors.

Keywords

Esophageal neoplasia Barrett’s esophagus Esophagogastric junction adenocarcinomas Early esophageal cancers Endoscopic mucosal resection Endoscopic submucosal dissection Radio-frequency ablation Siewert classification Esophagectomy 

References

  1. 1.
    Thrift AP, Whiteman DC. The incidence of esophageal adenocarcinoma continues to rise: analysis of period and birth cohort effects on recent trends. Ann Oncol. 2012;23(12):3155–62.CrossRefGoogle Scholar
  2. 2.
    Drahos J, Wu M, Anderson WF, et al. Regional variations in esophageal cancer rates by census region in the United States, 1999–2008. PLoS One. 2013;8(7):e67913.CrossRefGoogle Scholar
  3. 3.
    Lagergren J, Bergstrom R, Lindgren A, et al. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999;340(11):825–31.CrossRefGoogle Scholar
  4. 4.
    Lubin JH, Cook MB, Pandeya N, et al. The importance of exposure rate on odds ratios by cigarette smoking and alcohol consumption for esophageal adenocarcinoma and squamous cell carcinoma in the Barrett’s esophagus and esophageal adenocarcinoma consortium. Cancer Epidemiol. 2012;36(3):306–16.CrossRefGoogle Scholar
  5. 5.
    Hoyo C, Cook MB, Kamangar F, et al. Body mass index in relation to oesophageal and oesophagogastric junction adenocarcinomas: a pooled analysis from the international BEACON consortium. Int J Epidemiol. 2012;41(6):1706–18.CrossRefGoogle Scholar
  6. 6.
    Pohl H, Wrobel K, Bojarski C, et al. Risk factors in the development of esophageal adenocarcinoma. Am J Gastroenterol. 2013;108(2):200–7.CrossRefGoogle Scholar
  7. 7.
    Drahos J, Xiao Q, Risch HA, et al. Age-specific risk factor profiles of adenocarcinomas of the esophagus: a pooled analysis from the international BEACON consortium. Int J Cancer. 2016;138(1):55–64.CrossRefGoogle Scholar
  8. 8.
    Siewert JR, Stein HJ. Classification of adenocarcinoma of the oesophagogastric junction. Br J Surg. 1998;85(11):1457–9.CrossRefGoogle Scholar
  9. 9.
    Blot WJ, Devesa SS, Kneller RW, et al. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA. 1991;265(10):1287–9.CrossRefGoogle Scholar
  10. 10.
    Hansson LE, Sparen P, Nyren O. Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985. Br J Surg. 1993;80(3):374–7.CrossRefGoogle Scholar
  11. 11.
    Ekstrom AM, Signorello MB, Hansson LE, et al. Evaluating gastric cancer misclassification: a potential explanation for the raise in cardia cancer incidence. J Natl Cancer Inst. 1999;91(9):786–90.CrossRefGoogle Scholar
  12. 12.
    Wayman J, Forman D, Griffin SM. Monitoring the changing pattern of esophagogastric cancer: data from a UK regional cancer registry. Cancer Causes Control. 2001;12(10):943–9.CrossRefGoogle Scholar
  13. 13.
    Buas MF, Vaughan TL. Epidemiology and risk factors for gastroesophageal junction tumors: understanding the rising incidence of this disease. Semin Radiat Oncol. 2013;23(1):3–9.CrossRefGoogle Scholar
  14. 14.
    Kusano C, Gotoda T, Khor CJ, et al. Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan. J Gastroenterol Hepatol. 2008;23(11):1662–5.CrossRefGoogle Scholar
  15. 15.
    Jankowski JA, Harrison RF, Perry I, et al. Barrett’s neoplasia. Lancet. 2000;356(9247):2079–85.CrossRefGoogle Scholar
  16. 16.
    Carneiro F, Moutinho C, Pera G, et al. Pathology findings and validation of gastric and esophageal cancer cases in a European cohort (EPIC/EUR-GAST). Scand J Gastroenterol. 2007;42(5):618–27.CrossRefGoogle Scholar
  17. 17.
    Derakhshan MH, Malekzadeh R, Watabe H, et al. Combination of gastric atrophy, reflux symptoms and histological subtype indicates two distinct aetiologies of gastric cardia cancer. Gut. 2008;57(3):298–305.CrossRefGoogle Scholar
  18. 18.
    Horii T, Koike T, Abe Y, et al. Two distinct types of cancer of different origin may be mixed in gastroesophageal junction adenocarcinomas in Japan: evidence from direct evaluation of gastric acid secretion. Scand J Gastroenterol. 2011;46(6):710–9.CrossRefGoogle Scholar
  19. 19.
    Glickman JN, Chen YY, Wang HH, et al. Phenotypic characteristics of a distinctive multilayered epithelium suggests that it is a precursor in the development of Barrett’s esophagus. Am J Surg Pathol. 2001;25(5):569–78.CrossRefGoogle Scholar
  20. 20.
    Goldblum JR. Inflammation and intestinal metaplasia of the gastric cardia: Helicobacter pylori, gastroesophageal reflux disease, or both. Dig Dis. 2000;18(1):14–9.CrossRefGoogle Scholar
  21. 21.
    Hansen S, Vollset SE, Derakhshan MH, et al. Two distinct aetiologies of cardia cancer; evidence from premorbid serological markers of gastric atrophy and Helicobacter pylori status. Gut. 2007;56(7):918–25.CrossRefGoogle Scholar
  22. 22.
    Iijima K, Shimosegawa T. Gastric carditis: is it a histological response to high concentrations of luminal nitric oxide? World J Gastroenterol. 2006;12(36):5767–71.CrossRefGoogle Scholar
  23. 23.
    Crane SJ, Locke GR 3rd, Harmsen WS, et al. Subsite-specific risk factors for esophageal and gastric adenocarcinoma. Am J Gastroenterol. 2007;102(8):1596–602.CrossRefGoogle Scholar
  24. 24.
    Nobukawa B, Abraham SC, Gill J, et al. Clinicopathologic and molecular analysis of high-grade dysplasia and early adeno- carcinoma in short- versus long-segment Barrett esophagus. Hum Pathol. 2001;32(4):447–54.CrossRefGoogle Scholar
  25. 25.
    Ichihara S, Uedo N, Gotoda T. Considering the esophagogastric junction as a ‘zone’. Dig Endosc. 2017;29(Suppl 2):3–10.CrossRefGoogle Scholar
  26. 26.
    Kuwano H, Nishimura Y, Oyama T, et al. Guidelines for diagnosis and treatment of carcinoma of the esophagus April 2012 edited by the Japan Esophageal Society. Esophagus. 2015;12:1–30.CrossRefGoogle Scholar
  27. 27.
    Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2014 (ver. 4). Gastric Cancer. 2017;20:1–19.CrossRefGoogle Scholar
  28. 28.
    Yoshinaga S, Gotoda T, Kusano C, et al. Clinical impact of endoscopic submucosal dissection for superficial adenocarcinoma located at the esophagogastric junction. Gastrointest Endosc. 2008;67(2):202–9.CrossRefGoogle Scholar
  29. 29.
    Hirasawa K, Kokawa A, Oka H, et al. Superficial adenocarcinoma of the esophagogastric junction: long-term results of endoscopic submucosal dissection. Gastrointest Endosc. 2010;72(5):960–6.CrossRefGoogle Scholar
  30. 30.
    Yamada M, Oda I, Nonaka S, et al. Long-term outcome of endoscopic resection of superficial adenocarcinoma of the esophagogastric junction. Endoscopy. 2013;45(12):992–6.CrossRefGoogle Scholar
  31. 31.
    Ishihara R, Oyama T, Abe S, et al. Risk of metastasis in adenocarcinoma of the esophagus: a multicenter retrospective study in a Japanese population. J Gastroenterol. 2017;52(7):800–8.CrossRefGoogle Scholar
  32. 32.
    Goda K, Singh R, Oda I, et al. Current status of endoscopic diagnosis and treatment of superficial Barrett’s adenocarcinoma in Asia-Pacific region. Dig Endosc. 2013;25(Suppl 2):146–50.CrossRefGoogle Scholar
  33. 33.
    Yamagata T, Hirasawa D, Fujita N, et al. Efficacy of acetic acid- spraying method in diagnosing extension of Barrett’s cancer under the squamous epithelium. Dig Endosc. 2012;24(5):309–14.CrossRefGoogle Scholar
  34. 34.
    Hatta W, Uno K, Koike T, et al. Feasibility of optical coherence tomography for the evaluation of Barrett’s mucosa buried underneath esophageal squamous epithelium. Dig Endosc. 2016;28(1):427–33.CrossRefGoogle Scholar
  35. 35.
    Chennat J, Ross AS, Konda VJ, et al. Advanced pathology under squamous epithelium on initial EMR specimens in patients with Barrett’s esophagus and high-grade dysplasia or intramucosal carcinoma: implications for surveillance and endotherapy management. Gastrointest Endosc. 2009;70(3):417–21.CrossRefGoogle Scholar
  36. 36.
    Nagami Y, Machida H, Shiba M, et al. Clinical efficacy of endoscopic submucosal dissection for adenocarcinomas of the esophagogastric junction. Endosc Int Open. 2014;2(1):E15–20.CrossRefGoogle Scholar
  37. 37.
    Tokioka S, Umegaki E, Takeuchi N, et al. A case of the Barrett’s adenocarcinoma with intramucosal spread extending. Gastroenterol Endosc. 2010;52(1):402–11.Google Scholar
  38. 38.
    Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer. 2011;14:101–12.CrossRefGoogle Scholar
  39. 39.
    Yamashita H, Katai H, Morita S, et al. Optimal extent of lymph node dissection for Siewert type II esophagogastric junction carcinoma. Ann Surg. 2011;254(2):274–80.CrossRefGoogle Scholar
  40. 40.
    Fujitani K, Miyashiro I, Mikata S, et al. Pattern of abdominal nodal spread and optimal abdominal lymphadenectomy for advanced Siewert type II adenocarcinoma of the cardia: results of a multicenter study. Gastric Cancer. 2013;16(3):301–8.CrossRefGoogle Scholar
  41. 41.
    Mine S, Sano T, Hiki N, et al. Lymphadenectomy around the left renal vein in Siewert type II adenocarcinoma of the oesophagogastric junction. Br J Surg. 2013;100(2):261–6.CrossRefGoogle Scholar
  42. 42.
    Gilbert W, Luna RA, Harrison VL, Hunter JC. Barrett’s esophagus: a review of the literature. J Gastrointest Surg. 2011;15(5):708–18.CrossRefGoogle Scholar
  43. 43.
    Sikkema M, Looman CV, Steyerberg EW, et al. Predictors for neoplastic progression in patients with Barrett’s esophagus: a prospective cohort study. Am J Gastroenterol. 2011;106(7):1231–8.CrossRefGoogle Scholar
  44. 44.
    Hillman LC, Chiragakis L, Clarke AC, et al. Barrett’s esophagus: macroscopic markers and the prediction of dysplasia and adenocarcinoma. J Gastroenterol Hepatol. 2003;18(5):526–33.CrossRefGoogle Scholar
  45. 45.
    Bahin FF, Jayanna M, Hourigan LF, et al. Long-term outcomes of a primary complete endoscopic resection strategy for short segment Barrett’s esophagus with high-grade dysplasia and/or early esophageal adenocarcinoma. Gastrointest Endosc. 2016;83(1):68–77.CrossRefGoogle Scholar
  46. 46.
    Dumbar KB, Spechler SJ. The risk of lymph node metastases in patients with high grade dysplasia or intramucosal carcinoma in Barrett’s esophagus: a systemic review. Am J Gastroenterol. 2012;107(6):850–63.CrossRefGoogle Scholar
  47. 47.
    Luna RA, Gilbert E, Hunter JG. High-grade dysplasia and intarmucosal adenocarcinoma in Barrett’s esophagus: the role of esophagectomy in the era of endoscopic eradication therapy. Curr Opin Gastroenterol. 2012;28(4):362–9.CrossRefGoogle Scholar
  48. 48.
    Pech O, Behrens A, May A, et al. Long term results and risk factors analysis for recurrence after curative endoscopic therapy in 349 patients with high-grade intraepithelial neoplasia and mucosal adenocarcinoma in Barrett’s oesophagus. Gut. 2008;57(9):1200–6.CrossRefGoogle Scholar
  49. 49.
    Sgourakis G, Gockel I, Lang H. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systemic review. World J Gastroenterol. 2013;19(9):1424–37.CrossRefGoogle Scholar
  50. 50.
    Prasad GA, Wu TT, Wigle D, et al. Endoscopic and surgical treatment of mucosal (T1a) esophageal adenocarcinoma in Barrett’s esophagus. Gastroenterology. 2009;137(3):815–23.CrossRefGoogle Scholar
  51. 51.
    Yang D, Zou F, Xiong S, et al. Endoscopic submucosal dissection for early Barrett’s neoplasia: a meta-analysis. Gastrointest Endosc. 2018;87(6):1383–93.CrossRefGoogle Scholar
  52. 52.
    Ma MX, Bourke MJ. Endoscopic submucosal dissection in the west: current status and future directions. Dig Endosc. 2017;30:310.  https://doi.org/10.1111/den.12960.CrossRefPubMedGoogle Scholar
  53. 53.
    Chevaux JB, Psvaux H, Jouret-Mourin A, et al. Clinical outcome in patients treated with endoscopic submucosal dissection for superficial Barrett’s neoplasia. Endoscopy. 2015;47(3):103–12.CrossRefGoogle Scholar
  54. 54.
    Probst A, Aust D, Markl B, et al. Early esophageal cancer in Europe: endoscopic treatment by endoscopic submucosal dissection. Endoscopy. 2015;47(3):113–21.PubMedGoogle Scholar
  55. 55.
    Terheggen G, Horn EM, Vieth M, et al. A randomized trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett’s neoplasia. Gut. 2017;66(5):783–93.CrossRefGoogle Scholar
  56. 56.
    Moss A, Bourke MJ, Hourigan LF, et al. Endoscopic resection for Barrett’s high grade dysplasia and early esophageal adenocarcinoma: an essential staging procedure with long term therapeutic benefit. Am J Gastroenterol. 2010;105(6):1276–83.CrossRefGoogle Scholar
  57. 57.
    Subramaniam S, Chedgy F, Longcroft-Wheaton G, et al. Complex early Barrett’s neoplasia at 3 western centers: European Barrett’s Endoscopic Submucosal Dissection Trial (E-BEST). Gastrointest Endosc. 2017;86(4):608–18.CrossRefGoogle Scholar
  58. 58.
    Zehtner J, Demeester SR, Hagen J, et al. Endoscopic resection and ablation versus esophagectomy for high grade dysplasia and intramucosal adenocarcinoma. J Thorac Cardiovasc Surg. 2011;141(1):39–47.CrossRefGoogle Scholar
  59. 59.
    Ngamruengphong S, Wolfsen HC, Wallace MB. Survival of patients with superficial esophageal adenocarcinoma following endoscopic treatment vs surgery. Clin Gastroenterol Hepatol. 2013;11(11):1424–e81.CrossRefGoogle Scholar
  60. 60.
    Raziee HR, Cardoso R, Seevaratnam R, et al. Systematic review of the predictors of positive margins in gastric cancer surgery and the effect on survival. Gastric Cancer. 2012;15(Suppl 1):S116–24.CrossRefGoogle Scholar
  61. 61.
    Kamada T, Kurose H, Yamanaka Y, et al. Relationship between gastroesophageal junction adenocarcinoma and Helicobacter pylori infection in Japan. Digestion. 2012;85(4):256–60.CrossRefGoogle Scholar
  62. 62.
    Kusano C, Gotoda T, Kaltenbach T, et al. Differences in the endoscopic detection rates of Barrett’s esophagus using the Japanese and western criteria: a pilot study. Esophagus. 2016;13(2):25–9.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2019

Authors and Affiliations

  • Takuji Gotoda
    • 1
  • Antonello Trecca
    • 2
  1. 1.Division of Gastroenterology and Hepatology, Department of MedicineNihon University School of MedicineTokyoJapan
  2. 2.Gastroenterology and Operative Endoscopic UnitsI-Salus Project GroupRomeItaly

Personalised recommendations